A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer

    Fang Yan
    Fang Yan
    Siyu Miao
    Siyu Miao
    Manli Wu
    Manli Wu
    Xiaodan Huang
    Xiaodan Huang
    Youli Luo
    Youli Luo
    Cong Zhou
    Cong Zhou

    Cancer medicine, Volume 6, Issue 5, 2017, Pages 953-961.

    Cited by: 1|Bibtex|Views6|Links
    WOS
    Keywords:
    ALKNSCLCclinicopathological characteristicscrizotinibreal-world study

    Abstract:

    Crizotinib has achieved astonishing success in advanced non-small-cell lung cancer (NSCLC) patients harboring anaplastic lymphoma kinase (ALK) rearrangement. However, no real-world studies described the clinicopathological characteristics and treatment of such patients in China. Patients were consecutively collected from Sun Yat-sen Unive...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments